FDA approves new ovarian cancer drug
Friday, December 19, 2014 - 21:00
in Health & Medicine
Opening a new chapter in the use of genomic science to fight cancer, the Food & Drug Administration on Friday approved olaparib, a medication for advanced ovarian cancer associated with a defective BRCA gene.